4:13 PM
 | 
Aug 20, 2013
 |  BC Extra  |  Top Story

Adimab in two more discovery deals

Adimab LLC (Lebanon, N.H.) announced two separate discovery deals for its yeast-based antibody discovery technology on Tuesday. Adimab will use the technology to identify human antibodies against an undisclosed target selected by Innovent Biologics Inc. (Suzhou, China). Innovent will compensate Adimab for the discovery and optimization of lead compounds. Innovent...

Read the full 239 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >